Hypermarcas (OTCMKTS:HYPMY – Get Free Report)’s stock price crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $4.51 and traded as high as $4.51. Hypermarcas shares last traded at $4.41, with a volume of 33,566 shares trading hands.
Analyst Upgrades and Downgrades
Separately, Zacks Research raised shares of Hypermarcas to a “hold” rating in a research note on Wednesday, April 29th. One analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Buy”.
Get Our Latest Stock Report on Hypermarcas
Hypermarcas Stock Up 0.2%
Hypermarcas (OTCMKTS:HYPMY – Get Free Report) last issued its quarterly earnings results on Wednesday, April 29th. The company reported $0.10 earnings per share (EPS) for the quarter. The company had revenue of $383.13 million during the quarter. Hypermarcas had a net margin of 19.41% and a return on equity of 14.08%. Research analysts expect that Hypermarcas will post 0.53 EPS for the current year.
About Hypermarcas
Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.
Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.
See Also
- Five stocks we like better than Hypermarcas
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
- CAVA Group’s Stock Looks Delicious After Strong Earnings
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
Receive News & Ratings for Hypermarcas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypermarcas and related companies with MarketBeat.com's FREE daily email newsletter.
